Impact of generic antiretroviral drugs introduction on pharmaceutical expenditure patterns in the Netherlands: a six-year retrospective database analysis from 2016 to 2022

Impact of generic antiretroviral drugs introduction on pharmaceutical expenditure patterns in the Netherlands: a six-year retrospective database analysis from 2016 to 2022

Abstract Background In the Netherlands, the annual expenditure on HIV care was reported as €202 million in 2019, with about 70% allocated to antiretroviral therapy (ART). The introduction of generic antiretroviral medications (ARVs) in 2017 has offered potential cost-saving opportunities in healthca...

Full description

Saved in:
Bibliographic Details
Main Authors: P. Oosterhof, M. Van Luin, J. W. Vanhommerig, K. Brinkman, D. M. Burger
Format: Article
Language:English
Published: BMC 2025-05-01
Series:BMC Health Services Research
Subjects:
Antiretroviral therapy
HIV
Cost of care
Generic antiretroviral therapy
Pharmaceutical expenditure
Economic evaluation
Online Access:https://doi.org/10.1186/s12913-025-12816-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items